Validations: Deviation Handling & Batch Definition in CM
Common Deviation Themes in CM—and Preventive Controls Common Deviation Themes in Continuous Manufacturing—and Preventive Controls Continuous Manufacturing (CM) has revolutionized the pharmaceutical production landscape, offering significant advantages in efficiency and product quality. However, with new methodologies, the potential for deviations also increases. This tutorial provides insights into common themes of deviation and preventive controls necessary for maintaining compliance with regulations…
Documentation Architecture for CM Events In the era of continuous manufacturing (CM), where processes are streamlined for enhanced efficiency, the necessity for robust documentation architecture becomes paramount. This guide serves as a comprehensive tutorial on developing a documentation framework that meets strict regulatory standards while supporting real-time release testing (RTRT) and process analytical technology (PAT). Attention will be given to…
Multi-Site CM Deviations: Network Governance In the evolving landscape of pharmaceutical production, particularly within continuous manufacturing (CM), the necessity for robust governance structures has never been more apparent. Multisite operations introduce unique challenges, especially in the realms of adherence to regulatory parameters and deviation management. This tutorial serves as a step-by-step guide for professionals in clinical operations, regulatory affairs, and…
Auditing CM Deviations: What to Sample and Review Auditing CM Deviations: What to Sample and Review The increasing complexity and regulatory demands of the pharmaceutical industry necessitate robust auditing practices, especially in continuous manufacturing (CM). As firms venture into advanced methodologies such as real-time release testing (RTRT) and process analytical technology (PAT), understanding how to effectively audit deviations becomes crucial…
Batch Release After Deviation: Risk and Rationale Batch Release After Deviation: Risk and Rationale The complexities of pharmaceutical manufacturing necessitate rigorous adherence to regulatory standards, especially in scenarios involving deviations during the batch release process. This article provides a comprehensive tutorial on the methodology and risk management approaches associated with batch release after deviation, focusing on continuous manufacturing, process analytical…
Rework and Reprocessing in CM: Rules and Records Rework and Reprocessing in Continuous Manufacturing: Rules and Records The pharmaceutical industry continually innovates to enhance the manufacturing processes that ensure compliance with Good Manufacturing Practices (cGMP) under the scrutiny of global regulatory bodies such as the US FDA, EMA, and MHRA. A significant aspect of these innovations is the application of…
OOS/OOT in Continuous Data: Detection and Trending Understanding OOS/OOT in Continuous Data: Detection and Trending Introduction to Out of Specifications (OOS) and Out of Trend (OOT) in Continuous Manufacturing Within the realm of pharmaceutical validation, the need for robust mechanisms to address deviations such as Out of Specification (OOS) and Out of Trend (OOT) is essential, especially in the continuous…
Change Control Links to Deviation Patterns in Continuous Manufacturing Change control and deviation management are essential components of pharmaceutical validation, particularly in the context of continuous manufacturing (CM) and real-time release testing (RTRT). This article provides a step-by-step tutorial designed for pharmaceutical professionals involved in clinical operations, regulatory affairs, and quality assurance. Here, we will explore the intricate interrelationships between…
Regulatory Language for CM Deviations in Filings Regulatory Language for CM Deviations in Filings Continuous manufacturing (CM) represents a paradigm shift in pharmaceutical production, aiming to enhance efficiency and product quality. However, successful implementation requires a robust regulatory framework, especially concerning deviations during the process. This article aims to provide a comprehensive step-by-step tutorial on identifying, documenting, and handling deviations…
Human Error in Continuous Manufacturing: Error-Proofing and Training In the increasingly sophisticated landscape of pharmaceutical manufacturing, the need for stringent compliance with cGMP regulations and standards is paramount. Human error remains a significant risk factor that can compromise the integrity of processes, especially within continuous manufacturing (CM) systems. This article provides a comprehensive, step-by-step guide to error-proofing and training in…